ロード中...
Rasagiline and Rapid Symptomatic Motor Effect in Parkinson’s Disease: Review of Literature
Rasagiline is a monoamine oxidase type-B inhibitor used as monotherapy or in addition to levodopa in the treatment of Parkinson’s disease. Once daily administration of rasagiline makes it easy to use, and allows good compliance by patients and adherence to therapy. Several multicenter studies have n...
保存先:
| 出版年: | Neurol Ther |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4381918/ https://ncbi.nlm.nih.gov/pubmed/26000219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-013-0014-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|